Digestive Diseases and Sciences

, Volume 45, Issue 6, pp 1121–1129

Is Crohn's Disease an Immunodeficiency?

  • Joshua R. Korzenik
  • Brian K. Dieckgraefe
Article

Abstract

The current hypothesis for the etiology of Crohn's disease proposes an excessive immune response, largely T-cell driven, possibly against endogenous bacteria. Standard therapy is therefore directed towards suppression of this immune response. An alternative theory of pathogenesis accounts for epidemiologic and pathophysiologic observations that have been hitherto underemphasized, namely, (1) genetic disorders with deficiencies in neutrophil function can give rise to a clinical and pathologic syndrome indistinguishable from Crohn's; (2) abnormal neutrophil function is well described in Crohn's disease; (3) a group of bacteria implicated in other chronic inflammatory disorders causes impairment of neutrophil function; and (4) 20th century environmental risk factors for Crohn's disease may directly suppress neutrophil function and may have led to a shift in the dominant gut flora with similar effects. We propose that some cases of Crohn's disease result from the interaction of environmental and genetic influences leading to impaired mucosal neutrophil function, resulting in failure to effectively clear intramucosal microbes effectively. While encompassing existing data, this hypothesis proposes a proximate defect in the mucosal immune response. If this paradigm were correct, new therapeutic approaches might involve strategies to alter intestinal flora and stimulate neutrophil function.

Crohn's disease inflammatory bowel disease immunodeficiency neutrophil 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

REFERENCES

  1. 1.
    Elson C: The basis of current and future therapy for inflammatory bowel disease. Am J Med 100:656–662, 1996PubMedGoogle Scholar
  2. 2.
    Sartor RB: Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases. Am J Gastroenterol 92(12 suppl): 5S–11S, 1997Google Scholar
  3. 3.
    Lopez-Cubero S, Sullivan K, McDonald G: Course of Crohn's disease after allogeneic marrow transplantation. Gastroenterology 114:433–440, 1998PubMedGoogle Scholar
  4. 4.
    Sustento-Reodica N, Ruiz P, Rogers A, Viciana AL, Conn HO, Tzakis AG: Recurrent Crohn's disease in transplanted bowel. Lancet 349(9053):688–691, 1997PubMedGoogle Scholar
  5. 5.
    Werlin SL, Chusid MJ, Caya J, Oechler HW: Colitis in chronic granulomatous disease. Gastroenterology 82(2):328–331, 1982PubMedGoogle Scholar
  6. 6.
    Lindahl JA, Williams FH, Newman SL: Small bowel obstruction in chronic granulomatous disease. J Pediat Gastroenterol Nutr 3(4):637–640, 1984Google Scholar
  7. 7.
    Isaacs D, Wright VM, Shaw DG, Raafat F, Walker-Smith JA: Chronic granulomatous disease mimicking Crohn's disease. J Pediatr Gastroenterol Nutr 4(3):498–501, 1985PubMedGoogle Scholar
  8. 8.
    Fisher JE, Khan AR, Heitlinger L, Allen JE, Afshani E: Chronic granulomatous disease of childhood with acute ulcerative colitis: A unique association. Pediat Pathol 7(1):91–96, 1987Google Scholar
  9. 9.
    Ahlin A, De Boer M, Roos D, Leusen J, Smith CI, Sundin U, Rabbani H, Palmblad J, Elinder G: Prevalence, genetics and clinical presentation of chronic granulomatous disease in Sweden. Acta Paediatr 84(12):1386–1394, 1995PubMedGoogle Scholar
  10. 10.
    Rosh JR, Tang HB, Mayer L, Groisman G, Abraham SK, Prince A: Treatment of intractable gastrointestinal manifestations of chronic granulomatous disease with cyclosporine. J Pediat 126(1):143–145, 1995PubMedGoogle Scholar
  11. 11.
    Sloan JM, Cameron CH, Maxwell RJ, McCluskey DR, Collins JS: Colitis complicating chronic granulomatous disease. A clinicopathological case report. Gut 38(4):619–622, 1996Google Scholar
  12. 12.
    Hoare S, Walsh JE, Eastham E, Abinun MA, Cant AJ: Abnormal technetium labelled white cell scan in the colitis of chronic granulomatous disease. Arch Dis Child 77(1):50–51, 1997PubMedGoogle Scholar
  13. 13.
    Myrup B, Valerius NH, Mortensen PB: Treatment of enteritis in chronic granulomatous disease with granulocyte colony stimulating factor. Gut 42(1):127–130, 1998PubMedGoogle Scholar
  14. 14.
    Roe TF, Thomas DW, Gilsanz V, Isaacs H, Jr., Atkinson JB: Inflammatory bowel disease in glycogen storage disease type Ib. J Pediatr 109(1):55–59, 1986PubMedGoogle Scholar
  15. 15.
    Sanderson IR, Bisset WM, Milla PJ, Leonard JV: Chronic inflammatory bowel disease in glycogen storage disease type 1B. J Inherit Metab Dis 14(5):771–776, 1991PubMedGoogle Scholar
  16. 16.
    Couper R, Kapelushnik J, Griffiths AM: Neutrophil dysfunction in glycogen storage disease Ib: Association with Crohn's like colitis. Gastroenterology 100(2):549–554, 1991PubMedGoogle Scholar
  17. 17.
    Roe TF, Coates TD, Thomas DW, Miller JH, Gilsanz V: Brief report: Treatment of chronic inflammatory bowel disease in glycogen storage disease type Ib with colony-stimulating factors. N Engl J Med 326(25):1666–1669, 1992PubMedGoogle Scholar
  18. 18.
    Wendel U, Schroten H, Burdach S, Wahn V: Glycogen storage disease type Ib: Infectious complications and measures for prevention. European J Pediatr 152(suppl 1):S49–S51, 1993Google Scholar
  19. 19.
    Schulman H, Weizman Z, Barki Y, Maor E, Hertzanu Y: Inflammatory bowel disease in glycogen storage disease type 1 B. Pediatr Radiol 25(suppl 1):S160–S162, 1995PubMedGoogle Scholar
  20. 20.
    Hoover EG, DuBois JJ, Samples TL, McCullough JS, Chenaille PJ, Montes RG: Treatment of chronic enteritis in glycogen storage disease type IB with granulocyte colony-stimulating factor. J Pediatr Gastroenterol Nutr 22(4):346–350, 1996PubMedGoogle Scholar
  21. 21.
    Franceschini R, Gianetta E, Pastorino A, Dallegri F, Cataldi A, Corsini G, Barreca T: Crohn's-like colitis in glycogen storage disease Ib: A case report. Hepato-Gastroenterol 43(12):1461–1464, 1996Google Scholar
  22. 22.
    D'Agata ID, Paradis K, Chad Z, Bonny Y, Seidman E: Leukocyte adhesion deficiency presenting as a chronic ileocolitis. Gut 39:605–608, 1996PubMedGoogle Scholar
  23. 23.
    Ishii E, Matui T, Iida M, Inamitu T, Ueda K: Chediak-Higashi syndrome with intestinal complication. Report of a case. J Clin Gastroenterol 9(5):556–558, 1987PubMedGoogle Scholar
  24. 24.
    Knudtzon J, Ledaal P, Middelthon-Moe M, Aarskog D: 45,X/ 47,XY,+13 mosaicism and Crohn's disease. Acta Paediatr Scand 77(6):922–924, 1988PubMedGoogle Scholar
  25. 25.
    Knudtzon J, Svane S: Turner's syndrome associated with chronic inflammatory bowel disease. A case report and review of the literature. Acta Med Scand 223(4):375–378, 1988PubMedGoogle Scholar
  26. 26.
    Kohler JA, Grant DB: Crohn's disease in Turner's syndrome. Br Med J Clin Res Ed 282(6268):950, 1981Google Scholar
  27. 27.
    Vannier JP, Arnaud-Battandier F, Ricour C, Schmitz J, Buriot D, Griscelli C, Rey J: Chronic neutropenia and Crohn's disease in childhood. Arch Fr Pediatr 39(6):367–370, 1982PubMedGoogle Scholar
  28. 28.
    Fata F, Myers P, Addeo J, Grinberg M, Nawabi I, Cappell MS: Cyclic neutropenia in Crohn's ileocolitis: Efficacy of granulocyte colony-stimulating factor. J Clin Gastroenterol 24(4):253–256, 1997PubMedGoogle Scholar
  29. 29.
    Lamport RD, Katz S, Eskreis D: Crohn's disease associated with cyclic neutropenia. Am J Gastroenterol 87(11):1638–1642, 1992PubMedGoogle Scholar
  30. 30.
    Stevens C, Peppercorn MA, Grand RJ: Crohn's disease associated with autoimmune neutropenia. J Clin Gastroenterol 13(3):328–330, 1991PubMedGoogle Scholar
  31. 31.
    Harewood GC, Loftus EV, Teffen A, Tremaine WJ, Sandborn WJ: Concurrent inflammatory bowel disease and melodysplastic syndromes. Inflammatory Bowel Diseases 5:98–103, 1999PubMedGoogle Scholar
  32. 32.
    Harewood G, Loftus E, Sanborn W, Tremaine W: Concurrent inflammatory bowel disease and the leukemias. Gastroenterology 114:A992, 1998Google Scholar
  33. 33.
    D'Agata I, Paradis K, Chad Z, Bonny Y, Seidman E: Leucocyte adhesion deficiency presenting as a chronic ileocolitis. Gut 39:605–608, 1996PubMedGoogle Scholar
  34. 34.
    Baehner RL: Chronic granulomatous disease of childhood: Clinical, pathological, biochemical, molecular, and genetic aspects of the disease. Pediatr Pathol 10(1–2):143–153, 1990PubMedGoogle Scholar
  35. 35.
    Lopez-Osuna M, Vega-Avila E, Salamanca F, Kretschmer RR: Defective polymorphonuclear chemotaxis in patients with Turner's syndrome (45,X). Clin Genet 34(3):165–171, 1988PubMedGoogle Scholar
  36. 36.
    Vaughan D, Drumm B: Treatment of fistulas with granulocyte colony-stimulating factor in a patient with Crohn's disease. N Engl J Med 340(3):239–240, 1999PubMedGoogle Scholar
  37. 37.
    Segal AW, Loewi G: Neutrophil dysfunction in Crohn's disease. Lancet 2(7979):219–221, 1976PubMedGoogle Scholar
  38. 38.
    O'Morain C, Segal AA, Walker D, Levi AJ: Abnormalities of neutrophil function do not cause the migration defect in Crohn's disease. Gut 22(10):817–822, 1981PubMedGoogle Scholar
  39. 39.
    Verspaget HW, Pena AS, Weterman IT, Lamers CB: Diminished neutrophil function in Crohn's disease and ulcerative colitis identified by decreased oxidative metabolism and low superoxide dismutase content. Gut 29(2):223–228, 1988PubMedGoogle Scholar
  40. 40.
    Curran FT, Allan RN, Keighley MR: Superoxide production by Crohn's disease neutrophils. Gut 32(4):399–402, 1991PubMedGoogle Scholar
  41. 41.
    Gionchetti P, Campieri M, Guarnieri C, Belluzzi A, Brignola C, Bertinelli E, Ferretti M, Miglioli M, Barbara L: Respiratory burst of circulating polymorphonuclear leukocytes and plasma elastase levels in patients with inflammatory bowel disease in remission. Dig Dis Sci 39(3):550–554, 1994PubMedGoogle Scholar
  42. 42.
    Curran FT, Youngs DJ, Allan RN, Keighley MR: Candidacidal activity of Crohn's disease neutrophils. Gut 32(1):55–60, 1991PubMedGoogle Scholar
  43. 43.
    Wandall JH: Function of exudative neutrophilic granulocytes in patients with Crohn's disease or ulcerative colitis. Scand J Gastroenterol 20(9):1151–1156, 1985PubMedGoogle Scholar
  44. 44.
    Okabe N, Ikura S, Uchida Y, Fujita K, Yao T: Immunological studies on Crohn's disease. VIII. Diminished phagocytic activity in peripheral blood monocytes. J Clin Lab Immunol 32(1):29–31, 1990PubMedGoogle Scholar
  45. 45.
    Elmgreen J: Complement and function of neutrophils in chronic inflammatory bowel disease. Dan Med Bull 33(5):222–228, 1986PubMedGoogle Scholar
  46. 46.
    Clemens DL, Horwitz MA: Characterization of the Mycobacterium tuberculosis phagosome and evidence that phagosomal maturation is inhibited. J Exp Med 181(1):257–270, 1995PubMedGoogle Scholar
  47. 47.
    Dell'Angelica E, Shotelersuk V, Aguilar R, Gahl W, Bonifacino J: Altered trafficking of lysosomal proteins in Hermansky-Pudlak syndrome due to mutations in the beta 3A subunit of the AP-3 adaptor. Mol Cell 3:11–21, 1999PubMedGoogle Scholar
  48. 48.
    Yamanaka R, Barlow C, Lekstrom-Himes J, Castilla LH, Liu PP, Eckhaus M, Decker T, Wynshaw-Boris A, Xanthopoulos KG: Impaired granulopoiesis, myelodysplasia, and early lethality in CCAAT/enhancer binding protein epsilon-deficient mice. Proc Natl Acad Sci USA 94(24):13187–13192, 1997PubMedGoogle Scholar
  49. 49.
    Yamanaka R, Kim GD, Radomska HS, Lekstrom-Himes J, Smith LT, Antonson P, Tenen DG, Xanthopoulos KG: CCAAT/enhancer binding protein epsilon is preferentially upregulated during granulocytic differentiation and its functional versatility is determined by alternative use of promoters and differential splicing. Proc Natl Acad Sci USA 94(12):6462–6467, 1997PubMedGoogle Scholar
  50. 50.
    Takeda K, Clausen BE, Kaisho T, Tsujimura T, Terada N, Forster I, Akira S: Enhanced Th1 activity and development of chronic entercolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 10:39–49, 1999PubMedGoogle Scholar
  51. 51.
    Tysk C, Lindberg E, Jarnerot G, Floderus-Myrhed B: Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut 29:990–996, 1988PubMedGoogle Scholar
  52. 52.
    Wilson M, Reddi K, Henderson B: Cytokine-inducing components of periodontopathogenic bacteria. J Periodont Res 31:393–407, 1996PubMedGoogle Scholar
  53. 53.
    Hart TC, Shapira L, Van Dyke TE: Neutrophil defects as risk factors for periodontal diseases. J Periodontol 65(5 suppl):521–529, 1994PubMedGoogle Scholar
  54. 54.
    Van Dyke T, Vaikuntam J: Neutrophil function and dysfunction in periodontal disease. Curr Opin Peridontol 2:19–27, 1994Google Scholar
  55. 55.
    Van Dyke TE, Offenbacher S, Place D, Dowell VR, Jones J: Refractory periodontitis: Mixed infection with Bacteroides gingivalis and other unusual Bacteroides species. A case report. J Periodontol 59(3):184–189, 1988PubMedGoogle Scholar
  56. 56.
    Van Dyke TE, Dowell VR Jr, Offenbacher S, Snyder W, Hersh T: Potential role of microorganisms isolated from periodontal lesions in the pathogenesis of inflammatory bowel disease. Infect Immun 53(3):671–677, 1986PubMedGoogle Scholar
  57. 57.
    Wilton JM, Hurst TJ, Scott EE: Inhibition of polymorphonuclear leucocyte phagocytosis by Porphyromonas gingivalis culture products in patients with adult periodontitis. Arch Oral Biol 38(4):285–289, 1993PubMedGoogle Scholar
  58. 58.
    Ohta H, Kokeguchi S, Fukui K, Kato K: Leukotoxic activity in Actinobacillus (Haemophilus) actinomycetemcomitans isolated from periodontal disease patients. Microbiol Immunol 31(4):313–325, 1987PubMedGoogle Scholar
  59. 59.
    Scragg MA, Turton LR, Newman HN, Williams DM: Effects of Porphyromonas gingivalis culture products on the morphology of peripheral blood polymorphonuclear leucocytes from periodontitis patients and healthy subjects. J Clin Periodontol 22(8):585–590, 1995PubMedGoogle Scholar
  60. 60.
    Janowitz HD, Croen EC, Sachar DB: The role of the fecal stream in Crohn's disease: An historical and analytic review. Inflamm Bowel Dis 4(1):29–39, 1998PubMedGoogle Scholar
  61. 61.
    Harper PH, Lee EC, Kettlewell MG, Bennett MK, Jewell DP: Role of the faecal stream in the maintenance of Crohn's colitis. Gut 26(3):279–284, 1985PubMedGoogle Scholar
  62. 62.
    Keighley MR, Arabi Y, Dimock F, Burdon DW, Allan RN, Alexander-Williams J: Influence of inflammatory bowel disease on intestinal microflora. Gut 19(12):1099–1104, 1978PubMedGoogle Scholar
  63. 63.
    Giaffer MH, Holdsworth CD, Duerden BI: The assessment of faecal flora in patients with inflammatory bowel disease by a simplified bacteriological technique. J Med Microbiol 35(4):238–243, 1991PubMedGoogle Scholar
  64. 64.
    Favier C, Neut C, Mizon C, Cortot A, Colombel JF, Mizon J: Fecal beta-D-galactosidase production and Bifidobacteria are decreased in Crohn's disease. Dig Dis Sci 42(4):817–822, 1997PubMedGoogle Scholar
  65. 65.
    Rotstein OD, Vittorini T, Kao J, McBurney MI, Nasmith PE, Grinstein S: A soluble Bacteroides by-product impairs phagocytic killing of Escherichia coli by neutrophils. Infect Immun 57(3):745–753, 1989PubMedGoogle Scholar
  66. 66.
    Madsen KL, Taverini MM, Doyle JSG, RN. F: Lactobacillus SP prevents development of enterocolitis in interleukin-10 gene deficient mice. Gastroenterology 112:A1030, 1997Google Scholar
  67. 67.
    Mao Y, Nobaek S, Kasravi B, Adawi D, Stenram U, et al: The effects of Lactobacillus strains and oat fiber on methotrexateinduced enterocolitis in rats. Gastroenterology 111:334–344, 1996PubMedGoogle Scholar
  68. 68.
    Muscettola M, Massal L, Tanganelli C, Grasso G: Effects of lactobacilli on interferon production in young and aged mice. Ann NY Acad Sci 717:226–232, 1994PubMedGoogle Scholar
  69. 69.
    Wagner RD, Pierson C, Warner T, Dohnalek M, Farmer J, Roberts L, Hilty M, Balish E: Biotherapeutic effects of probiotic bacteria on candidiasis in immunodeficient mice. Infect Immun 65:4165–4172, 1997PubMedGoogle Scholar
  70. 70.
    Crohn BB, Ginzburg L, Oppenheimer GD: Regional enteritis: A pathologic and clinical entity. J Am Med Assoc 99:1323–1329, 1932Google Scholar
  71. 71.
    Tomkins AM, Bradley AK, Oswald S, Drasar BS: Diet and the faecal microflora of infants, children and adults in rural Nigeria and urban UK. J Hyg 86:285–293, 1981Google Scholar
  72. 72.
    Koletzko S, Sheman P, Corey M, Griffiths A, Smith C: Role of infant feeding practices in development of Crohn's disease in childhood. Br Med J 298:1617–1618, 1989Google Scholar
  73. 73.
    Wiedemann W, Ketterle A, Naujoks R: Dental studies on the protective effect of breast feeding. Dtsche Zahnaerztl Z 34:427–429, 1979Google Scholar
  74. 74.
    Beerens H, Romond C, Neut C: Influence of breast-feeding on the bifid flora of the newborn intestine. Am J Clin Nutr 33:2434–2439, 1980PubMedGoogle Scholar
  75. 75.
    Martini G, Brandes J: Increased consumption of refined carbohydrates in patients with Crohn's disease. Klin Woschenshr 54:367–371, 1976Google Scholar
  76. 76.
    Persson P-G, Tysk C, Anderson K, Jarnerot G: Smoking and inflammatory bowel disease. A control study. Gut 29:352–357, 1988Google Scholar
  77. 77.
    Forrest E, Graham E, Russell R: Crohn's Arthropathy and NSAIDS: Associations and therapeutic difficulties. Gastroenterology 114:A978, 1998Google Scholar
  78. 78.
    Evans J, McMahon A, Murray F, McDevitt D, MacDonald T: Nonsteroidal anti-inflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease. Gut 40:619–622, 1997PubMedGoogle Scholar
  79. 79.
    MacFarlane GD, Herzberg MC, Wolff LF, Hardie NA: Refractory periodontitis associated with abnormal polymorphonuclear leukocyte phagocytosis and cigarette smoking. J Periodontol 63(11):908–913, 1992PubMedGoogle Scholar
  80. 80.
    Genco RJ: Current view of risk factors for periodontal diseases. J Periodontol 67(10 suppl):1041–1049, 1996PubMedGoogle Scholar
  81. 81.
    Pabst MJ, Pabst KM, Collier JA, Coleman TC, Lemons-Prince ML, Godat MS, Waring MB, Babu JP: Inhibition of neutrophil and monocyte defensive functions by nicotine. J Periodontol 66(12):1047–1055, 1995PubMedGoogle Scholar
  82. 82.
    Sasagawa S, Suzuki K, Sakatani T, Fujikura T: Effects of nicotine on the functions of human polymorphonuclear leukocytes in vitro. J Leukoc Biol 37(5):493–502, 1985PubMedGoogle Scholar
  83. 83.
    Sasagawa S, Kameda H, Sudo J, Tanabe T: Inhibitory effect of nicotine on chemiluminescence response of human polymorphonuclear leukocytes stimulated by opsonized zymosan in vitro. J Toxicol Sci 9(1):1–9, 1984Google Scholar
  84. 84.
    Smith J, Walker J: The effects of some antirheumatic drugs on an in vitro model of human polymorphonuclear leucocyte chemotaxis. Br J Pharmacol 69:473–478, 1980PubMedGoogle Scholar
  85. 85.
    Nikolaus S, Bauditz J, Gionchetti P, Witt C, Lochs H, Schreiber S: Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammation. Gut 42(4):470–476, 1998PubMedGoogle Scholar
  86. 86.
    Murch SH, Braegger CP, Walker-Smith JA, MacDonald TT: Location of tumour necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease. Gut 34(12):1705–1709, 1993PubMedGoogle Scholar
  87. 87.
    Prantera C, Zannoni F, Scribano ML, Berto E, Andreoli A, Kohn A, Luzi C: An antibiotic regimen for the treatment of active Crohn's disease: A randomized, controlled clinical trial of metronidazole plus ciprofloxacin. Am J Gastroenterol 91(2):328–332, 1996PubMedGoogle Scholar
  88. 88.
    Bernstein L, Frank M, Brandt L: Healing of perineal Crohn's disease with metronidazole. Gastroenterology 79:357–365, 1980PubMedGoogle Scholar
  89. 89.
    Burnham W, Lennard-Jones J, Hecketsweiler P, Colin R, Geffroy Y: Oral BCG vaccine in Crohn's disease. Gut 20:229–233, 1979PubMedGoogle Scholar
  90. 90.
    Sachar D, Rubin K, Gumaste V: Levamisole in Crohn's disease: A randomized, double-blind, controlled trial. Am J Gastroenterol 82:536–539, 1987PubMedGoogle Scholar
  91. 91.
    Wesdorp E, Schellekens PT, Weening RS, Meuwissen SG, Tytgat GN: Levamisole in Crohn's disease—a double-blind controlled trial. Digestion 18(3–4):186–191, 1978PubMedGoogle Scholar
  92. 92.
    Gionchetti P, Rizzello F, Venturi A, et al: Maintenance treatment of chronic pouchitis: A randomized, controlled trial with a new probiotic preparation. Gastroenterology 114:A985, 1998Google Scholar
  93. 93.
    Ament ME, Ochs HD: Gastrointestinal manifestations of chronic granulomatous disease. N Engl J Med 288(8):382–387, 1973PubMedGoogle Scholar
  94. 94.
    Yogman MW, Touloukian RJ, Gallagher R: Intestinal granulomatosis in chronic granulomatous disease and in Crohn's disease. N Engl J Med 290(4):228, 1974Google Scholar
  95. 95.
    Harris BH, Boles ET Jr: Intestinal lesions in chronic granulomatous disease of childhood. J Pediatr Surg 8(6):955–956, 1973PubMedGoogle Scholar
  96. 96.
    Wendel U, Bremer HJ, Willberg B: Inflammatory bowel disease in glycogen storage disease type Ib. J Pediatr 110(1):166, 1987Google Scholar
  97. 97.
    Miyasaki KT: The neutrophil: mechanisms of controlling periodontal bacteria. J Periodontol 62:761–774, 1991PubMedGoogle Scholar

Copyright information

© Plenum Publishing Corporation 2000

Authors and Affiliations

  • Joshua R. Korzenik
    • 1
  • Brian K. Dieckgraefe
    • 1
  1. 1.Division of Gastroenterology, Department of Internal MedicineWashington University School of MedicineSt. Louis

Personalised recommendations